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Purpose: To evaluate the anatomical and functional results obtained with pars plana vitrectomy 
(PPV) plus autologous platelet concentrate (APC) as a treatment for macular detachment associ-
ated with optic disc pit (ODP).
Methods: We performed a prospective interventional study of 19 eyes of 19 consecutive patients 
with posterior macular detachment due to ODP. All patients underwent PPV, posterior hyaloid 
peeling, fluid–air exchange, injection of 0.05 mL of APC over the ODP and 15% perfluoropro-
pane (C3F8) endotamponade. Postoperative measures included face-up positioning for 2 hours 
and then avoidance of the face-up position during the ensuing 10 days. All patients underwent 
complete ophthalmologic examination and optical coherence tomography preoperatively at 
1 month, 3 months, 6 months, 9 months, and 12 months postoperatively and then annually. 
Outcome measures were best corrected visual acuity (BCVA) by logMAR, improvement of 
quality of vision, macular attachment, and resolution of intraretinal schisis-like separation.
Results: Preoperatively, the median BCVA was 0.70 (range: 0.30–1.70) and all patients showed 
improved visual acuity after surgery; BCVA was 0.22 (range: 0.07–0.52) at 12 months follow-up. 
All patients showed complete reabsorption of intraretinal fluid (median time: 3.5 months [range: 
2–8 months]) and macular attachment at the end of follow-up (median: 60 months [range: 
12–144 months]), with stable or improved visual acuity. No reoperations were needed and no 
major adverse events were recorded.
Conclusion: For macular detachment associated with ODP, the combination of PPV, posterior 
hyaloid peeling, APC, and C3F8 tamponade is a highly effective alternative technique with 
stable anatomical and functional results.
Keywords: macular detachment, optic disc pit, maculopathy, retinoschisis, pars plana vitrec-
tomy, autologous platelet concentrate
Introduction
Optic disc pits (ODPs) are congenital anomalies of the optic nerve head, first described 
by Wiethe1 in 1882 as black cavities on the optic nerve head observed in one eye 
of a 62-year-old woman. The prevalence of ODP is estimated to be one in every 
11,000 patients.2,3 In about 70% of cases, the ODPs are located on the temporal side 
of the disc and 85%–90% are unilateral.4,5 Visual acuity is usually unaffected unless 
the ODPs are associated with macular pathology, such as macular detachment, retino-
schisis-like separation, outer layer macular hole, and retinal pigment epithelial atrophy. 
Macular detachment develops in one-third to two-thirds of patients, which may occur 
in childhood or later, the mean being at 30 years of age.6,7 Vascular abnormalities such 
as colobomas and epipapillary membranes may also be associated.
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The complete pathogenesis of ODP-related maculopathy 
remains unclear. It is assumed that fluid passes through the 
ODP and enters the sensory retina creating a schisis-like 
separation.8–10 However, the source of the fluid is contro-
versial. Two major possible sources have been proposed: 
vitreous cavity or cerebrospinal fluid.11–14 Other possible 
sources are abnormal vessels or vasculature with increased 
vascular permability.15 Some authors have suggested a 
rhegmatogenous etiology with a small hole or tear in the 
membrane overlying the pit, which supports the notion that 
fluid leaks from the vitreous cavity.16,17 Based on this hypoth-
esis, our therapeutic approach was to seal the theoretical 
communication between the vitreous cavity and the retina 
with autologous platelet concentrate (APC), which has been 
shown to promote tissue healing and successful results in 
macular hole surgery,18–22 in order to address the etiology of 
the maculopathy. The purpose of the present study was to 
evaluate the anatomical and functional results obtained with 
pars plana vitrectomy (PPV) plus APC and gas tamponade 
as treatment of ODP-related maculopathy.
Methods
We performed a prospective interventional study of 19 eyes 
of 19 consecutive patients with macular detachment associ-
ated with congenital ODP, treated between January 2001 
and January 2013 at Centro de Oftalmología Barraquer, 
Barcelona, Spain and Vissum Madrid, Madrid, Spain. All 
patients had a preoperative visual acuity of 20/40 or worse 
and no concomitant macular disease.
Preoperatively, we recorded the best corrected visual acuity 
(BCVA) by logMAR, and intraocular pressure. All patients 
underwent anterior and posterior segment slit-lamp biomicros-
copy, using a 90 diopter noncontact lens, and optical coherence 
tomography (OCT). The Ethical Committee of clinical research 
of Centro de Oftalmología Barraquer approval was obtained 
and informed consent was obtained from all patients.
Surgery was performed by two surgeons, one at each 
participating center, using three-port 20 or 23-gauge PPV. 
The posterior hyaloid was detached to remove any vitreo-
retinal tractions. The internal limiting membrane (ILM) was 
not removed in any case. Before fluid–air exchange, careful 
peripheral fundus examination was performed. Under air, 
approximately 0.05 mL of APC was injected over the ODP, 
sufficient to cover the ODP and the optic disc cup. This was 
followed by air–15% perfluoropropane (C3F8) gas tampon-
ade exchange, to expel subretinal and intraretinal fluid and 
promote reabsorption. Postoperative measures included 
face-up positioning for 2 hours, to keep the APC in contact 
with the ODP, and avoidance of the face-up position for the 
ensuing 10 days, in order to isolate the macula from fluid with 
long-acting gas. Lens extraction surgery plus intraocular lens 
implantation was not performed in patients under 50 years 
of age (number =16; 84.2%).
APC was prepared as described by our group in a previous 
report.23 Briefly, blood samples were transferred to a sterile 
tube containing ethylenediaminetetraacetic acid. The con-
tents were centrifuged at 1,000 rpm for 10 minutes at 10°C. 
The lower one-third of plasma, which is rich in platelets, 
was aspirated and centrifuged again. Part of the plasma was 
removed, leaving the platelets adhered to the tube walls. The 
platelets thus obtained were dissolved in saline solution to 
yield a concentration of ~1,000,000 platelets/mm3.
Postoperatively, BCVA and intraocular pressure were 
recorded; anterior and posterior segment slit-lamp biomi-
croscopy, using a 90 diopter noncontact lens, and OCT were 
performed at 1 month, 3 months, 6 months, 9 months, and 12 
months, and then annually (spectral-domain Cirrus or Stratus; 
Carl Zeiss Meditec AG, Jena, Germany). Outcome measures 
were BCVA, improvement in quality of vision, macular 
attachment, and resolution of schisis-like intraretinal separa-
tion assessed by OCT. BCVA and visual improvement data 
were statistically analyzed using SPSS version 17. Results are 
expressed as the median and range for continuous variables 
and as the frequency (percentage) for categorical variables. 
The Wilcoxon test for repeated measures, with 95% confidence 
intervals, was used to analyze pre- and postoperative BCVA.
Results
Nineteen patients (median age: 30 years; range: 13–62 years; 
ten women [52.6%]) were included in the present study. 
ODP and macular detachment were present in nine right eyes 
(47.4%) and ten left eyes (52.6%) (Table 1).
Preoperatively, all patients had decreased BCVA and 
10/19 had associated metamorphopsia during a median of 
3 months (range: 0.25–24 months). Three patients (cases 
12, 13, and 14) had previous PPV, laser at the temporal 
edge of the optic nerve head, and gas tamponade as a first 
treatment of the ODP-related maculopathy without success. 
In the preoperative examination, all patients presented with 
macular detachment associated with ODP. One patient had 
complete posterior vitreous detachment (PVD), eight patients 
had incomplete PVD, and the remaining ten patients did not 
have PVD. The median BCVA was 0.70 (range: 0.30–1.70). 
The median refractive error was 0 diopters (range: -6.50 
to +3.00). OCT showed macular detachment in all cases, 
with variable degrees of intraretinal schisis-like separation 
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in 17/19 patients (89.5%). ILM detachment was not present 
in any case. Outer layer macular hole was present in 4/19 
cases (21.1%). In two cases, OCT showed a communication 
between the vitreous cavity and the retina (Figure 1).
No complications or adverse events were recorded dur-
ing surgery. Interestingly, in two cases, while the residual 
vitreous cavity fluid was being removed from the optic disc, 
the submacular fluid was aspirated through the ODP and 
the macula was reattached. It was in these two cases where 
communication between the vitreous cavity and the retina 
was seen on OCT. No iatrogenic lesions were recorded. Two 
patients had lens extraction plus intraocular lens implantation 
at the same surgical time.
The median follow-up was 60 months (range: 12–144 
months). Postoperatively, all patients showed improved 
visual acuity after surgery. The median BCVA was 0.22 
(range: 0.07–0.52) at 12-month follow-up, the difference 
being statistically significant (P,0.05) in comparison with 
preoperative values. BCVA remained stable in 7/19 cases 
(36.8%) and increased in 12/19 cases (63.2%) at our last 
follow-up.
OCT showed complete resolution of intraretinal schisis-
like separation and macular detachment in all patients 
(Figure 2). Retinal fluid reabsorption time varied consider-
ably, with a median of 3.5 months (range: 2–8 months). 
Minute defects in the outer segment of photoreceptors and/or 
the inner segment/outer segment lines were observed with 
high-resolution OCT in all cases.
None of the patients had sight-threatening complications 
during follow-up. One patient (case 11) presented with infe-
rior exudative vitreous infiltrate, which disappeared 48 hours 
after surgery without repercussions. None of the patients 
needed reoperation during follow-up.
Discussion
ODP maculopathy usually manifests with macular 
detachment, resulting in visual loss. As reported by Lincoff 
et al24 macular detachment is associated with a schisis-like 
separation of the internal retinal layers in almost 90% of 
cases. In our study, 17/19 cases presented this separation 
associated to macular detachment at the first examination. 
Moreover, four of the 19 cases also presented with an outer 
layer lamellar macular hole.
Although spontaneous retinal attachment has been 
described in 25% of cases, the treatment of nonresolved cases 
remains controversial and the results are not encouraging. The 
following therapeutic approaches have been reported: laser 
therapy, to produce a chorioretinal adhesion barrier at the 
optic disc border;17,25,26 intravitreal gas injection;27 PPV with 
or without laser; ILM peeling; glial tissue removal; and/or 
air/gas exchange18,20,28–34 or macular scleral buckling.35
Initially, our group treated ODP-related macular detach-
ment with PPV, a photocoagulation barrier at the temporal 
optic disc border, plus gas. However, in our revision of 
43 eyes, macular detachment persisted in almost 30% of 
cases, requiring additional photocoagulation plus gas treat-
ment. After this second treatment, almost 80% of patients 
presented with macular attachment. As a result of our poor 
rates, we developed a new technique based on our experi-
ence with APC in macular hole surgery. In this regard, our 
group has reported successful treatment of recurrent macu-
lar detachment secondary to optic nerve coloboma with an 
overlying retinal hole treated with APC.23 This lends support 
to the hypothesis of a rhegmatogenous etiology to explain 
submacular fluid associated with both optic nerve head 
coloboma and ODP.14,36
The use of APC was first described by Rosenthal et al37 
in a patient with persistent macular detachment due to 
ODP, after vitrectomy, posterior hyaloid removal, and gas 
tamponade, with good anatomical and functional results at 
3 months of follow-up. However, their technique involved 
flute needle extraction of the subretinal fluid through the 
ODP, creating a communication between the vitreous and 
Figure 1 Optical coherence tomography showing the communication between the 
vitreous cavity and the retina (arrow) in two different cases.
Notes: Submacular fluid was aspirated during the vitrectomy. (A) Case 12; (B) 
Case 17.
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the subretinal space. Based on the hypothetical rhegmatog-
enous etiology of ODP-related macular detachment, our 
technique involves posterior hyaloid peeling to eliminate 
vitreous–macular traction, and APC injection over the ODP 
to promote healing of the suspected communication between 
the ODP and the sensory retina. The possible existence of 
communication at the level of the ODP is related to epipap-
illary fibrous tissue traction and incomplete PVD, allowing 
liquefied vitreous to pass through the ODP and dissect the 
retina, causing macular detachment or squisis.5,16,17,38 As in 
some cases described by other authors,14–17 two of our patients 
presented with a break in the tissue overlying the ODP, and 
the vitreous remained attached in both cases, visualized 
before and during surgery. We believe that the use of APC 
with its mitogenic and chemotactic properties,39 associated 
with posterior hyaloid peeling to eliminate vitreomacular 
traction, favors the proliferative cellular response and closure 
of the suspected communication between the vitreous and the 
retina and, secondarily, promotes reabsorption of intra- and 
subretinal fluid.
Our technique resulted in improved visual acuity in all 
cases, with a median gain of four Snellen lines. It also pro-
duced stable anatomical and functional improvement during 
a follow-up period of more than 5 years, without reoperation 
being required. Such results were not previously obtained by 
our group with complete PPV, photocoagulation, and gas 
tamponade alone. Furthermore, reabsorption of intra- and 
subretinal fluid occurred progressively and was completed 
within a median time of 4.5 months, which is in contrast 
to reabsorption times of approximately 1 year reported for 
other techniques, albeit with good results, such as macular 
vitrectomy or scleral buckling.33,35 This supports the hypoth-
esis of a rhegmatogenous etiology for ODP-related macular 
detachment, and the use of APC together with the release 
Figure 2 representative patient, case 17.
Notes: (A and B) Posterior segment photograph and OCT preoperatively and (C–F) postoperatively. (A) Fundus examination of the right eye presented an inferotemporal 
optic disc pit (black arrow) associated with macular detachment (white arrowheads) and an outer layer hole (white arrow). Preoperatively, the BCVa was 0.30 by logMar. 
(B) OCT showed macular detachment (#) with inner retinoschisis separation (arrow) and a lamellar macular hole (open white arrow); note the optic disc pit (white 
arrow) and communication with the schisis. (D) Postoperatively, the retina showed progressive attachment. at 1 month after vitrectomy, the inner retinoschisis and the 
macular detachment decreased, and the lamellar macular hole disappeared. at 3 months, there was (E) residual inner retinoschisis and macular detachment with subretinal 
precipitates, and (C and F) at 6 months, the retina was attached without inner retinoschisis and defects of the inner segment/outer segment line (white open arrowheads), 
and the BCVa was 0.10 by logMar.
Abbreviations: OCT, optical coherence tomography; BCVa, best corrected visual acuity.
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of posterior pole traction allowed us to achieve excellent 
results.
Conclusion
In conclusion, our technique with APC to treat ODP-related 
macular detachment proved highly successful in terms of 
progressive and stable anatomical and functional improve-
ment. As a promising alternative approach to conventional 
surgery, it appears to address the etiology of the problem. 
However, the limited sample size means that this technique 
requires prospective multicenter studies to confirm its 
effectiveness.
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